Evidence map›Paper›PMID 27403354›Full record

ArticleCase reports in hepatology2016

A Case of Primary Hepatic Lymphoma and Related Literature Review.

Yonghua Liu, Jinhong Jiang, Qinli Wu, Qiaolei Zhang, Yehui Xu, Zhigang Qu, Guangli Ma, Xiaoqiu Wang, Xiaoli Wang, Weimei Jin and 1 more

Abstract read
In one paragraph

Article in Case reports in hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Hypercalcemia due to Primary Hepatic Lymphoma.Case reports in hematology · 2016
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yonghua LiuDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Jinhong JiangDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Qinli WuDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Qiaolei ZhangDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Yehui XuDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Zhigang QuDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Guangli MaDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Xiaoqiu WangDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Xiaoli WangDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Weimei JinDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.
Bingmu FangDepartment of Hematology, Sixth Affiliated Hospital of Wenzhou Medical University, Lishui City, Zhejiang 323000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective. Primary hepatic lymphoma is a rare disease. And the clinical manifestations of this disease are nonspecific. The objective of this paper is to improve clinicians' understanding of this disease. Methods. We analyzed the clinical characteristics of a case of primary hepatic lymphoma in association with hepatitis B virus infection and reviewed the literature. Conclusion. The clinical manifestations of primary hepatic lymphoma are nonspecific. And it is easily misdiagnosed. Postoperative radiotherapy of patients with early stage was previously speculated to achieve favorable improvement. The application of targeted therapeutic drugs, chemotherapy, or combined local radiotherapy has become the first-line treatment strategy.

Identifiers

PMID27403354
PMCPMC4923573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.